Literature DB >> 18202239

Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade.

R Jain1, S K Ellika, L Scarpace, L R Schultz, J P Rock, J Gutierrez, S C Patel, J Ewing, T Mikkelsen.   

Abstract

BACKGROUND AND
PURPOSE: Glioma angiogenesis and its different hemodynamic features, which can be evaluated by using perfusion CT (PCT) imaging of the brain, have been correlated with the grade and the aggressiveness of gliomas. Our hypothesis was that quantitative estimation of permeability surface area product (PS), cerebral blood volume (CBV), cerebral blood flow (CBF), and mean transit time (MTT) in astroglial brain tumors by using PCT will correlate with glioma grade. High-grade gliomas will show higher PS and CBV as compared with low-grade gliomas.
MATERIALS AND METHODS: PCT was performed in 32 patients with previously untreated astroglial tumors (24 high-grade gliomas and 8 low-grade gliomas) by using a total acquisition time of 170 seconds. World Health Organization (WHO) glioma grades were compared with PCT parameter absolute values by using Student or nonparametric Wilcoxon 2-sample tests. Receiver operating characteristic (ROC) analyses were also done for each of the parameters.
RESULTS: The differences in PS, CBV, and CBF between the low- and high-grade tumor groups were statistically significant, with the low-grade group showing lower mean values than the high-grade group. ROC analyses showed that both CBV (C-statistic 0.930) and PS (C-statistic 0.927) were very similar to each other in differentiating low- and high-grade gliomas and had higher predictability compared with CBF and MTT. Within the high-grade group, differentiation of WHO grade III and IV gliomas was also possible by using PCT parameters, and PS showed the highest C-statistic value (0.926) for the ROC analyses in this regard.
CONCLUSIONS: Both PS and CBV showed strong association with glioma grading, high-grade gliomas showing higher PS and CBV as compared with low-grade gliomas. Perfusion parameters, especially PS, can also be used to differentiate WHO grade III from grade IV in the high-grade tumor group.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202239      PMCID: PMC7978188          DOI: 10.3174/ajnr.A0899

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  58 in total

1.  Defining a local arterial input function for perfusion MRI using independent component analysis.

Authors:  Fernando Calamante; Morten Mørup; Lars Kai Hansen
Journal:  Magn Reson Med       Date:  2004-10       Impact factor: 4.668

Review 2.  The role of blood-brain barrier permeability in brain tumor imaging and therapeutics.

Authors:  James M Provenzale; Srinivasan Mukundan; Mark Dewhirst
Journal:  AJR Am J Roentgenol       Date:  2005-09       Impact factor: 3.959

Review 3.  Update on brain tumor imaging: from anatomy to physiology.

Authors:  S Cha
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

Review 4.  Intratumor microvessel density as a prognostic factor in cancer.

Authors:  N Weidner
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

5.  Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macromolecular and small-molecular contrast media--preliminary experience.

Authors:  A Gossmann; Y Okuhata; D M Shames; T H Helbich; T P Roberts; M F Wendland; S Huber; R C Brasch
Journal:  Radiology       Date:  1999-10       Impact factor: 11.105

6.  Arterial input functions for dynamic susceptibility contrast MRI: requirements and signal options.

Authors:  Thomas E Conturo; Erbil Akbudak; Melanie S Kotys; Maison L Chen; Steve J Chun; Raymond M Hsu; Caitlin C Sweeney; Joanne Markham
Journal:  J Magn Reson Imaging       Date:  2005-12       Impact factor: 4.813

7.  Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors.

Authors:  H C Roberts; T P Roberts; A W Bollen; S Ley; R C Brasch; W P Dillon
Journal:  Acad Radiol       Date:  2001-05       Impact factor: 3.173

8.  Quantification of angiogenesis by functional computed tomography in a Matrigel model in rats.

Authors:  Sith Phongkitkarun; Satoshi Kobayashi; Zuxing Kan; Ting-Yim Lee; Chusilp Charnsangavej
Journal:  Acad Radiol       Date:  2004-05       Impact factor: 3.173

Review 9.  Imaging of angiogenesis: from microscope to clinic.

Authors:  Donald M McDonald; Peter L Choyke
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

10.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

Authors:  K H Plate; G Breier; H A Weich; W Risau
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

View more
  57 in total

Review 1.  Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors.

Authors:  Hemant Sarin
Journal:  Ther Deliv       Date:  2010-08

2.  In vivo correlation of tumor blood volume and permeability with histologic and molecular angiogenic markers in gliomas.

Authors:  R Jain; J Gutierrez; J Narang; L Scarpace; L R Schultz; N Lemke; S C Patel; T Mikkelsen; J P Rock
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-11       Impact factor: 3.825

Review 3.  Permeability imaging in pediatric brain tumors.

Authors:  Sandi Lam; Yimo Lin; Peter C Warnke
Journal:  Transl Pediatr       Date:  2014-07

4.  MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas.

Authors:  Chih-Chun Wu; Rajan Jain; Lucidio Neto; Seema Patel; Laila M Poisson; Jonathan Serrano; Victor Ng; Sohil H Patel; Dimitris G Placantonakis; David Zagzag; John Golfinos; Andrew S Chi; Matija Snuderl
Journal:  Neuroradiology       Date:  2019-05-27       Impact factor: 2.804

Review 5.  Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging.

Authors:  Rajan Jain; Jayant Narang; Pia M Sundgren; David Hearshen; Sona Saksena; Jack P Rock; Jorge Gutierrez; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2010-02-24       Impact factor: 4.130

6.  Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas.

Authors:  Na Zhang; Lijuan Zhang; Bensheng Qiu; Li Meng; Xiaoyi Wang; Bob L Hou
Journal:  J Magn Reson Imaging       Date:  2012-05-11       Impact factor: 4.813

7.  Correlation of perfusion parameters with genes related to angiogenesis regulation in glioblastoma: a feasibility study.

Authors:  R Jain; L Poisson; J Narang; L Scarpace; M L Rosenblum; S Rempel; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

8.  Estimation of perfusion properties with MR Fingerprinting Arterial Spin Labeling.

Authors:  Katherine L Wright; Yun Jiang; Dan Ma; Douglas C Noll; Mark A Griswold; Vikas Gulani; Luis Hernandez-Garcia
Journal:  Magn Reson Imaging       Date:  2018-03-12       Impact factor: 2.546

9.  Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT?

Authors:  Rajan Jain; Shehanaz Ellika; Norman L Lehman; Lisa Scarpace; Lonni R Schultz; Jack P Rock; Mark Rosenblum; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2009-10-15       Impact factor: 4.130

Review 10.  Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.

Authors:  Hemant Sarin
Journal:  J Transl Med       Date:  2009-09-01       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.